A1-reprogrammed mesenchymal stromal cells prime potent antitumoral responses

Summary: Mesenchymal stromal cells (MSCs) have been modified via genetic or pharmacological engineering into potent antigen-presenting cells-like capable of priming responding CD8 T cells. In this study, our screening of a variant library of Accum molecule revealed a molecule (A1) capable of eliciti...

Full description

Bibliographic Details
Published in:iScience
Main Authors: Marina Pereira Gonçalves, Roudy Farah, Jean-Pierre Bikorimana, Jamilah Abusarah, Nehme EL-Hachem, Wael Saad, Sebastien Talbot, Daniela Stanga, Simon Beaudoin, Sebastien Plouffe, Moutih Rafei
Format: Article
Language:English
Published: Elsevier 2024-03-01
Subjects:
Classification Description
Immunology
Pharmaceutical engineering
Cancer
Online Access:http://www.sciencedirect.com/science/article/pii/S2589004224004693

Internet

http://www.sciencedirect.com/science/article/pii/S2589004224004693

Similar Items